Our publications related to the project
Braun S, Paskas S, Laube M, George S, Hofmann B, Lönnecke P, Steinhilber D, Pietzsch J,
Mijatović S, Maksimović-Ivanić D, Evamarie Hey-Hawkins. In Vitro Cytostatic Effect on Tumor
Cells by Carborane-Based Dual Cyclooxygenase-2 and 5-Lipoxygenase Inhibitors. First
published: 22 December 2022 https://doi.org/10.1002/adtp.202200252
Useini L, Komazec T, Laube M, Lönnecke P, Schädlich J, Mijatović S, Maksimović-Ivanić D,
Pietzsch J, Hey-Hawkins E. Isonimesulide and Its Carborane Analogues as Isoform-Selective
COX Inhibitors and Antitumor Agents. Adv. Therap.2023, 2300117.
Braun S, Jelača S, Laube M, George S, Hofmann B, Lönnecke P, Steinhilber D, Pietzsch J,
Mijatović S, Maksimović-Ivanić D, Hey-Hawkins E. Synthesis and In Vitro Biological
Evaluation of p-Carborane-Based Di-tert-butylphenol Analogs. Molecules. 2023 Jun
4;28(11):4547.
Braun S, Paskaš S, Laube M, George S, Hofmann B, Lönnecke P, Steinhilber D, Pietzsch J,
Mijatović S, Maksimović-Ivanić D, Hey-Hawkins E. Carborane-Based Tebufelone Analogs and
Their Biological Evaluation In Vitro. ChemMedChem. 2023 May 9:e202300206. doi:
10.1002/cmdc.202300206. Online ahead of print.
Braun S, Paskaš S, Laube M, George S, Hofmann B, Lönnecke P, Steinhilber D, Pietzsch J,
Mijatović S, Maksimović-Ivanić D, Hey-Hawkins E. Carborane-Based Tebufelone Analogs and
Their Biological Evaluation In Vitro. ChemMedChem. 2023 May 9:e202300206. doi:
10.1002/cmdc.202300206. Online ahead of print.
Predarska I, Saoud M, Drača D, Morgan I, Komazec T, Eichhorn T, Mihajlović E, Dunđerović D,
Mijatović S, Maksimović-Ivanić D, Hey-Hawkins E, Kaluđerović GN. Mesoporous Silica
Nanoparticles Enhance the Anticancer Efficacy of Platinum(IV)-Phenolate Conjugates in Breast
Cancer Cell Lines. Nanomaterials (Basel). 2022 Oct 26;12(21):3767. doi:
10.3390/nano12213767.
Paskaš S, Murganić B, Kuhnert R, Hey-Hawkins E, Mijatović S, Maksimović-Ivanić D.
Carborane-Based Analog of Rev-5901 Attenuates Growth of Colon Carcinoma In Vivo. Molecules.
2022 Jul 14;27(14):4503. doi: 10.3390/molecules27144503.
Useini L, Mojić M, Laube M, Lönnecke P, Dahme J, Sárosi MB, Mijatović S, Maksimović-Ivanić
D, Pietzsch J, Hey-Hawkins E. Carboranyl Analogues of Mefenamic Acid and Their Biological
Evaluation. ACS Omega. 2022 Jun
Kuhnert R, Kuhnert L, Sárosi MB, George S, Draca D, Paskas S, Hofmann B, Steinhilber D,
Honscha W, Mijatović S, Maksimović-Ivanić D, Hey-Hawkins E. Borcalein: a Carborane-Based
Analogue of Baicalein with 12-Lipoxygenase-Independent Toxicity. ChemMedChem. 2022 Jan
5;17(1):e202100588. doi: 10.1002/cmdc.202100588. Epub 2021 Nov 11.
Buzharevski A, Paskaš S, Sárosi MB, Laube M, Lönnecke P, Neumann W, Murganić B, Mijatović S,
Maksimović-Ivanić D, Pietzsch J, Hey-Hawkins E. Carboranyl Derivatives of Rofecoxib with
Cytostatic Activity against Human Melanoma and Colon Cancer Cells. Sci Rep. 2020 Mar
16;10(1):4827. doi: 10.1038/s41598-020-59059-3.
Buzharevski A, Paskas S, Laube M, Lönnecke P, Neumann W, Murganic B, Mijatovic S,
Maksimovic-Ivanic D, Pietzsch J, Hey-Hawkins E. Carboranyl Analogues of Ketoprofen with
Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines. ACS Omega. 2019 May
23;4(5):8824-8833. doi: 10.1021/acsomega.9b00412
Buzharevski A, Paskas S, Sárosi MB, Laube M, Lönnecke P, Neumann W, Mijatovic S,
Maksimovic-Ivanic D, Pietzsch J, Hey-Hawkins E. Carboranyl Analogues of Celecoxib with
Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines. ChemMedChem.
2019 Feb 5;14(3):315-321.
Kuhnert R, Sárosi MB, George S, Lönnecke P, Hofmann B, Steinhilber D, Steinmann S,
Schneider-Stock R, Murganić B, Mijatović S, Maksimović-Ivanić D, Hey-Hawkins E.
Carborane-Based Analogues of 5-Lipoxygenase Inhibitors Co-inhibit Heat Shock Protein 90 in
HCT116 Cells. ChemMedChem. 2019 Jan 22;14(2):255-261.
Kuhnert R, Sárosi MB, George S, Lönnecke P, Hofmann B, Steinhilber D, Murganic B, Mijatovic
S, Maksimovic-Ivanic D, Hey-Hawkins E. CarbORev-5901: The First Carborane-Based Inhibitor of
the 5-Lipoxygenase Pathway. ChemMedChem. 2017; 12:1081-1086.
ADVANCED